Takafumi Ikeda

Safety and Antitumor Activity of Anti–PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer

Junzo Hamanishi, Masaki Mandai, Takafumi Ikeda et al. · Journal of Clinical Oncology · 2015 · 1.2K citations

Comparison of the Indocyanine Green Fluorescence and Blue Dye Methods in Detection of Sentinel Lymph Nodes in Early-stage Breast Cancer

Tomoharu Sugie, Terumasa Sawada, Nobumi Tagaya et al. · Annals of Surgical Oncology · 2013 · 155 citations

Breast Oncology, Engineering, Early-stage Breast Cancer +11

Design and Synthesis of Mg²⁺-Selective Fluoroionophores Based on a Coumarin Derivative and Application for Mg²⁺ Measurement in a Living Cell

Yoshio Suzuki, Hirokazu Komatsu, Takafumi Ikeda et al. · Analytical Chemistry · 2002 · 128 citations

Engineering, Mg2+ Versus Ca2+, Biomedical Engineering +19

Evaluation of the Clinical Utility of the ICG Fluorescence Method Compared with the Radioisotope Method for Sentinel Lymph Node Biopsy in Breast Cancer

Tomoharu Sugie, Takayuki Kinoshita, Norikazu Masuda et al. · Annals of Surgical Oncology · 2015 · 105 citations

Radioisotope Method, Breast Oncology, Engineering +12

A randomized controlled clinical trial of topical insulin-like growth factor-1 therapy for sudden deafness refractory to systemic corticosteroid treatment

Takayuki Nakagawa, Kozo Kumakawa, Shin‐ichi Usami et al. · BMC Medicine · 2014 · 86 citations · Full text